DarioHealth Corp
NASDAQ:DRIO
DarioHealth Corp
Revenue
DarioHealth Corp
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
DarioHealth Corp
NASDAQ:DRIO
|
Revenue
$20.4m
|
CAGR 3-Years
39%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$19.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$14.7B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$21B
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$40.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$7.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
DarioHealth Corp
Revenue Breakdown
Breakdown by Geography
DarioHealth Corp
Breakdown by Segments
DarioHealth Corp
Total Revenue:
20.4m
USD
|
Services:
13.1m
USD
|
Consumers:
8.3m
USD
|
See Also
What is DarioHealth Corp's Revenue?
Revenue
20.4m
USD
Based on the financial report for Dec 31, 2023, DarioHealth Corp's Revenue amounts to 20.4m USD.
What is DarioHealth Corp's Revenue growth rate?
Revenue CAGR 5Y
22%
Over the last year, the Revenue growth was -26%. The average annual Revenue growth rates for DarioHealth Corp have been 39% over the past three years , 22% over the past five years .